FDA Clarifies NDI Notification for Supplements vs Ingredients
October 20, 2011 By
The Analytical Partner You Trust
Pharmaceutical News
Supplements Usage, Consumer Confidence at Highest
U.S. consumers are not only using supplements more than ever before, they are also more confident than ever in the safety, quality, and efficacy of … [Read More...]
President Obama Issues Executive Order to Reduce
In response to the increase in drug shortages over the past three years, President Obama issued an executive order on Oct. 31, 2011 that directs FDA … [Read More...]
FDA Establishes Two Centers for Regulatory Science
On Oct. 26, 2011, FDA dedicated $2 million to support two regional Centers of Excellence in Regulatory Science and Innovation (CERSI). The centers, … [Read More...]
Facility Highlights
Our New 6490 Triple Quadrupole LC-MS/MS with
ADPEN brings aboard Agilent’s newest Triple Quadrupole LC-MS/MS, the 6490 with iFunnel technology. The 6490 has unprecedented sensitivity and is today’s most sensitive triple quadrupole mass spectrometer. It is designed to deliver high levels of sensitivity and robustness for even the most complex and demanding matrices. ADPEN has interfaced the 6490 with Agilent’s latest 1290 [...]
FDA- What’s New: Drugs
- Generic Drugs: Information for Industry February 22, 2012
- Orange Book Zip File February 22, 2012
- Current Drug Shortages February 22, 2012
- Newly Added Guidance Documents February 22, 2012
- Comunicado de la FDA sobre la seguridad de los medicamentos: Importantes interacciones entre el medicamento Victrelis (boceprevir) y los medicamentos inhibidores de la proteasa del virus de inmunodeficiencia humana (VIH) reforzados con ritonavir February 22, 2012